The Hemangioma and Vascular Malformation Center at Cincinnati Children’s is one of the largest comprehensive vascular anomaly centers in North America and includes two nationally recognized centers of excellence for hereditary hemorrhagic telangiectasia (HHT) and Sturge-Weber syndrome. We follow nearly 4,000 patients and perform approximately 600 new consultations each year. We evaluate and treat both children and adults with a wide variety of vascular tumors and malformations from all around the country and the world.
Our Team: A Wide Range of Expertise
The hemangioma and vascular malformation program is a partnership among Cincinnati Children’s Division of Hematology, Division of Pediatric Surgery and Division of Radiology with a commitment from a multitude of other subspecialties such as Otolaryngology (ENT), Plastic Surgery, Orthopedics, Neurology, Neurosurgery, Occupational and Physical Therapy, Pathology, Pulmonary, Ophthalmology, and Behavioral Medicine and Clinical Psychology.
Our team has expertise in the diagnosis and management of vascular anomalies as well as an in-depth understanding of the complex problems that patients may face. Our staff also includes nurses, a genetic counselor, psychologist, social worker, and physical and occupational therapists who provide vascular anomaly-focused support to patients and their families. Our team considers physical functioning as well as emotional and social well-being in the treatment approach for our patients.
Selected based on the unique needs of each patient, our providers work together and collaborate to establish an accurate diagnosis and to create an optimal treatment plan for each individual.
Located within the Cancer and Blood Diseases Institute, our center currently conducts a total of six to seven interdisciplinary clinics each month at either the Burnet Campus or Liberty Campus as well as four to five half-day clinics per month specifically for new patients with hemangiomas.
Research & Clinical Trials
The Hemangioma and Vascular Malformation Center also offers state-of-the-art facilities for diagnosis and treatment of complicated vascular anomalies that are not widely available at other centers. Our program is a leader in clinical and laboratory-based research of vascular anomalies with active participation in clinical trials for individuals with these complex conditions.